-
Inhibition of FAST-1 Molecule May Have Therapeutic Potential in Friedreich’s Ataxia
A study supports the hypothesis that inhibition of FAST-1, a naturally produced RNA molecule, may have potential for the treatment of Friedreich’s ataxia. Learn more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.